Evidence map›Paper›PMID 34724086›Full record

ReviewStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2022

The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry.

Tibor Major, Georgina Fröhlich, Péter Ágoston, Csaba Polgár, Zoltán Takácsi-Nagy

Open access · hybridAbstract readReview
In one paragraph

Review in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Status of head and neck brachytherapy in Spain in 2022.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  10. Investigating the impact of breast positioning control on physical treatment parameters in multi-catheter breast brachytherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  11. Article
  12. Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tibor MajorRadiotherapy Centre, National Institute of Oncology, Budapest, Hungary. major.tibor@oncol.hu.ORCID 0000-0002-4672-6910
Georgina FröhlichRadiotherapy Centre, National Institute of Oncology, Budapest, Hungary.ORCID 0000-0001-6428-6536
Péter ÁgostonRadiotherapy Centre, National Institute of Oncology, Budapest, Hungary.ORCID 0000-0003-0264-630X
Csaba PolgárRadiotherapy Centre, National Institute of Oncology, Budapest, Hungary.ORCID 0000-0001-7245-0762
Zoltán Takácsi-NagyRadiotherapy Centre, National Institute of Oncology, Budapest, Hungary.ORCID 0000-0002-3261-0271
Semmelweis University · HUEötvös Loránd University · HU

Funding

Hungarian Scientific Research Fund TKP2020-NKA-26
6 · The paper itself

Abstract

Brachytherapy (BT) has long been used for successful treatment of various tumour entities, including prostate, breast and gynaecological cancer. However, particularly due to advances in modern external beam techniques such as intensity-modulated radiotherapy (IMRT), volume modulated arc therapy (VMAT) and stereotactic body radiotherapy (SBRT), there are concerns about its future. Based on a comprehensive literature review, this article aims to summarize the role of BT in cancer treatment and highlight its particular dosimetric advantages. The authors conclude that image-guided BT supported by inverse dose planning will successfully compete with high-tech EBRT in the future and continue to serve as a valuable modality for cancer treatment.

Indexed as

BrachytherapyRadiotherapy, Intensity-ModulatedHumansMaleRadiometryRadiotherapy DosageRadiotherapy Planning, Computer-AssistedBrachytherapyComparisonDosimetryExternal beam therapyTreatment planning

Identifiers

PMID34724086
PMCPMC8789711
OpenAlexW3211281862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.